Oncology Words matter: The power of language in cancer discussions The priority for any individual diagnosed with cancer is to be provided an effective therapy as quickly as possible.
Views & Analysis Words, inclusivity, and the struggle for health equality Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.
Views & Analysis It’s time for new language in healthcare marketing Healthcare brands need some new terminology and new models.
R&D Ben Sidders on integrating causality in AI for R&D success Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
